HeartFlow Analysis vs Imbio PHA (4.0.0)
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you need a comprehensive, non-invasive assessment of coronary artery disease, including detailed 3D modeling, plaque characterization, and functional blood flow analysis (FFRct) from standard CT scans. This tool is ideal for precisely identifying and quantifying the impact of coronary blockages to guide treatment decisions without invasive procedures.
View HeartFlow Analysis →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if you require rapid, automated analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation. This is particularly useful for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing quick measurements of RV/LV and PA/Ao ratios.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | Imbio PHA (4.0.0) |
|---|---|---|
| Pricing | Contact vendor for pricing | Unknown |
| Deployment | Cloud-based (AWS) | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HeartFlow AnalysisHeartFlow Analysis offers an interactive experience with personalized 3D models and Roadmapu2122 Analysis, which helps clinicians read CCTA cases 25% faster while maintaining diagnostic accuracy. Its documentation is also interactive and context-sensitive, accessible directly within the cloud-based application. While Imbio PHA emphasizes full automation and direct PACS integration, HeartFlow's richer visualization and efficiency gains for complex tasks provide a superior user experience.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis boasts extensive clinical validation with over 600 peer-reviewed publications and studies on over 365,000 patients, demonstrating superior diagnostic performance for CAD compared to other non-invasive tests. Studies confirm its ability to change patient management and reduce unnecessary invasive procedures. While Imbio PHA is valuable for pulmonary embolism and hypertension risk stratification, HeartFlow's depth and breadth of clinical evidence are significantly greater.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis clearly outlines its economic value through a fee-for-service model with established Category I CPT codes (75580 and 75577 for 2026) and CMS payment rates, ensuring clear reimbursement pathways for providers. Imbio PHA only states 'contact for pricing,' offering no transparency regarding its reimbursement or economic value proposition.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers greater deployment flexibility, supporting cloud, on-premise (VMware), or integration via numerous partners like Nuance and Aidoc. This caters to diverse institutional IT infrastructures and data residency preferences. While HeartFlow lists comprehensive compliance certifications, Imbio's broader deployment options and explicit third-party HIPAA certification provide a stronger foundation for enterprise-wide adoption.
Innovation
HeartFlow AnalysisHeartFlow Analysis demonstrates greater innovation by utilizing AI for complex 3D modeling of coronary arteries, computational fluid dynamics (CFD) for blood flow simulation, and non-invasive Fractional Flow Reserve derived from CT (FFRct) analysis. This provides advanced functional physiological insights beyond the automated anatomical measurements offered by Imbio PHA.
Support & Docs
HeartFlow AnalysisHeartFlow Analysis offers a comprehensive support ecosystem, including hands-on training, technology integration, expert coding support, peer mentorship, and extensive educational and marketing materials. Its documentation is interactive, topic-based HTML5, and available in 12 languages. Imbio PHA provides standard support channels and user manuals, but HeartFlow's offerings are more extensive and proactive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | Imbio PHA (4.0.0) |
|---|---|---|
| Tool Name | HeartFlow Analysis | Imbio PHA (4.0.0) |
| Company | HeartFlow | Imbio |
| Primary Diagnostic Focus | Diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries. | Assessing potential right ventricular dilation and aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Key AI Functionality | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization), Computational Fluid Dynamics (CFD) for blood flow simulation. | Automated measurement of right and left ventricle diameters, automated measurement of main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios, utilizes artificial intelligence algorithms for anatomical identification and measurement. |
| Input Scan Type | Standard CT scans (coronary CT angiography - CCTA) | CT pulmonary angiogram (CTPA) scans |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and Imbio PHA (4.0.0).